You are here: Industry Insights > Sandoz

News List

Sandoz drives differentiated portfolio with deal to commercialize new treatment for Opioid-Induced Constipation in key European countries firstwordpharma
April 12, 2019
Rizmoic® is an innovative medicine for treating constipation caused by opioid pain relief medicines, in patients who have previously been treated with a laxative...
Sandoz exclusively launches treprostinil injection, the first generic version of Remodulin, in the US firstwordpharma
March 26, 2019
Sandoz today announced the US availability of Treprostinil Injection……
Novartis' Sandoz chief exits with 'de-integration' undone. Could a spinoff be next? fiercepharma
March 15, 2019
Novartis CEO Vas Narasimhan said in January that his company is focused on the “de-integration” of Sandoz from the rest of its operations.
Sandoz Canada receives Health Canada approval for Erelzi (etanercept) in the Treatment of Psoriatic Arthritis (PsA) in Adult Patients firstwordpharma
January 22, 2019
Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic arthritis (PsA) in adult patients.
Sandoz launches SYMJEPI in the US americanpharmaceuticalreview
January 21, 2019
Sandoz announced the US market introduction of SYMJEPI (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.....
Sandoz selects finalists in digital tech healthcare access competition pharmaphorum
January 17, 2019
Sandoz has selected three finalists in a competition to use digital technology to increase access to medicines in poorer countries.
Sandoz inks biosimilars commercialization deal with Gan & Lee Pharmaceutical biospectrumasia
January 07, 2019
Sandoz, recently announced that it has entered into an agreement with Gan & Lee Pharmaceutical to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes.
Sandoz joins medical cannabis drive with Tilray deal pharmaphorum
December 20, 2018
Novartis’ Sandoz subsidiary has taken its first steps into the emerging market for medical cannabis products, signing a global supply deal with Canadian producer Tilray.
Sandoz Enters Into Commercialization, Supply Agreement for Insulin Biosimilars americanpharmaceuticalreview
December 20, 2018
Sandoz has entered into an agreement to commercialize biosimilar versions of insulins used in patients with type 1 and type 2 diabetes.....
Sandoz and Ares Genetics partner to develop anti-infectives platform pharmaceutical-technology
December 19, 2018
Novartis division Sandoz has partnered with Ares Genetics to develop a digital anti-infectives platform to support drug development and life cycle management.....

Previous page 1 2 3 4 5 6 7 8 Next page